Seven Bridges Stock
Biomedical Data Science Company
Sign up today and learn more about Seven Bridges Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Seven Bridges Stock
Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.
First Star Ventures
Chief Executive Officer
Chief Financial Officer
Chief Technology Officer
genomeweb - Sep, 9 2021Seven Bridges, Scripps Research Win $7.5M Contract to Develop NIAID Data Ecosystem
bit - Aug, 26 2021RTI International Makes Investment in Seven Bridges Genomics
aithority - Mar, 4 2021Seven Bridges Announces Strategic Advisory Board Appointments
pharmiweb - Sep, 23 2020Seven Bridges Advances Workflow Automation Capabilities to Make Complex Multi-Omic Analysis More Accessible to Broader Mix of Users
zpr - Dec, 18 2019Seven Bridges Announces Mike Bigda as Chief Operating Officer
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase